Parkwood LLC’s NeoGenomics NEO Stock Holding History

Parkwood LLC’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-18,360	Closed	-$165K	–	330
2017 Q2	$165K	Buy	+18,360	New	+$146K	0.02%	399

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Parkwood LLC's NEO Position: Q3 2017 in Review

Parkwood LLC sold out of NeoGenomics (NEO) in Q3 2017, closing a stake of 18,360 shares — an estimated $165K sold.

Parkwood LLC first reported a position in NEO in Q2 2017 and held it in 1 quarter. The position peaked at $165K in Q2 2017. 139 funds tracked by Wall St. Rank hold NEO as of Q3 2017.

Parkwood LLC reported no remaining NeoGenomics position as of Q3 2017 after selling out during the quarter.
Parkwood LLC sold 18,360 NeoGenomics shares in Q3 2017, an estimated $165K.
Parkwood LLC first reported a position in NeoGenomics in Q2 2017 and held it in 1 quarter.
Parkwood LLC's NeoGenomics position peaked at $165K in Q2 2017.
139 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2017.

Based on Parkwood LLC's 13F filing for Q3 2017, filed 1 Nov 2017.